1,796
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Measures of dependence in menthol and nonmenthol smokers - A comprehensive narrative review

, PhD, MPH, CPHORCID Icon, , PhD, DABT, ATS & , PhD

References

  • Henningfield JE, Benowitz NL, Ahijevych K, Garrett BE, Connolly GN, Wayne GF. Does menthol enhance the addictiveness of cigarettes? An agenda for research. Nicotine Tob Res. 2003; 5:9–11. doi:10.1080/1462220031000070543.
  • Family Smoking Prevention and Tobacco Control Act (FSPTCA). Section 907 of the Federal Food, Drug, and Cosmetic Act - Tobacco Product Standards. http://www.fda.gov/tobaccoproducts/guidancecomplianceregulatoryinformation/ucm263053.htm (accessed March 27, 2019).
  • Tobacco Products Scientific Advisory Committee. Menthol cigarettes and public health: review of the scientific evidence and recommendations. https://wayback.archiveit.org/7993/20170405201731/ https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/TobaccoProductsScientificAdvisoryCommittee/UCM269697.pdf (accessed March 27,2019).
  • Food and Drug Administration. Preliminary scientific evaluation of the possible public health effects of menthol versus nonmenthol cigarettes. https://www.fda.gov/downloads/ucm361598.pdf (accessed March 27, 2019).
  • Food and Drug Administration. Reference addendum: preliminary scientific evaluation of the possible public health effects of menthol versus nonmenthol cigarettes. https://www.fda.gov/downloads/TobaccoProducts/Labeling/ProductsIngredientsComponents/UCM449273.pdf (accessed March 27, 2019).
  • Frost-Pineda K, Muhammad-Kah R, Rimmer L, Liang Q. Predictors, indicators, and validated measures of dependence in menthol smokers. J Addict Dis. 2014;33(2):94–113. doi:10.1080/10550887.2014.909696.
  • Committee on the Development of the Third Edition of the Reference Manual on Scientific Evidence, Committee on Science TLC, Policy and Global Affairs (PGA), Federal Judicial Center, National Research Council. Reference manual on scientific evidence. 3rd ed. Washington, DC: The National Academies Press; 2011.
  • International Agency for Research on Cancer. Methods for evaluating cancer control policies. Vol. 12. Lyon, France: International Agency for Research on Cancer; 2008. IARC Handbooks of Cancer Prevention.
  • U.S. Department of Health and Human Services. How tobacco smoke causes disease: the biology and behavioral basis for smoking - attributable disease: a report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2010.
  • National Cancer Institute. Phenotypes and endophenotypes: foundations for genetic studies of nicotine use and dependence. In: Swan GE, Baker TB, Chassin L, Conti DV, Lerman C, Perkins KA, editors. Tobacco Control Monograph No. 20. NIH Publication No. 09-6366. Washington, DC: National Institutes of Health, National Cancer Institute; 2009. U.S. Department of Health and Human Services.
  • Fagerström KO. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav. 1978;3:235–241. doi:10.1016/0306-4603(78)90024-2.
  • Fagerström KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerström tolerance questionnaire. J Behav Med. 1989;12:159–182. doi:10.1007/BF00846549.
  • Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict. 1991;86:1119–1127. doi:10.1111/j.1360-0443.1991.tb01879.x.
  • Fagerström KO. Determinants of tobacco use and renaming the FTND to the Fagerström test for cigarette dependence. Nicotine Tob Res. 2012;14:75–78.
  • Etter JF, Le Houezec J, Perneger TV. A self-administered questionnaire to measure dependence on cigarettes: the cigarette dependence scale. Neuropsychopharmacology. 2003;28:359–370. doi:10.1038/sj.npp.1300030.
  • Etter JF, Le Houezec J, Huguelet P, Etter M. Testing the Cigarette Dependence Scale in 4 samples of daily smokers: psychiatric clinics, smoking cessation clinics, a smoking cessation website and in the general population. Addict Behav. 2009;34:446–450. doi:10.1016/j.addbeh.2008.12.002.
  • Okuyemi KS, Pulvers KM, Cox LS, Thomas JL, Kaur H, Mayo MS, Nazir N, Etter JF, Ahluwalia JS. Nicotine dependence among African American light smokers: A comparison of three scales. Addict Behav. 2007;32:1989–2002. doi:10.1016/j.addbeh.2007.01.002.
  • Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict. 1989;84:791–800. doi:10.1111/j.1360-0443.1989.tb03059.x.
  • Shiffman S, Waters AJ, Hickcox M. The nicotine dependence syndrome scale: a multidimensional measure of nicotine dependence. Nicotine Tob Res. 2004;6:327–348. doi:10.1080/1462220042000202481.
  • Shiffman S, Sayette MA. Validation of the nicotine dependence syndrome scale (NDSS): a criterion-group design contrasting chippers and regular smokers. Drug Alcohol Depend. 2005;79:45–52. doi:10.1016/j.drugalcdep.2004.12.009.
  • DiFranza JR, Savageau JA, Rigotti NA, Ockene JK, McNeill AD, Coleman M, Wood C. Trait anxiety and nicotine dependence in adolescents: a report from the DANDY study. Addict Behav. 2004;29:911–919. doi:10.1016/j.addbeh.2004.02.021.
  • Piper ME, Piasecki TM, Federman EB, Bolt DM, Smith SS, Fiore MC, Baker TB. A multiple motives approach to tobacco dependence: the Wisconsin inventory of smoking dependence motives (WISDM-68) J Consult Clin Psychol. 2004;72:139–154. doi:10.1037/0022-006X.72.2.139.
  • Smith SS, Piper ME, Bolt DM, Fiore MC, Wetter DW, Cinciripini PM, Baker TB. Development of the brief Wisconsin inventory of smoking dependence motives. Nicotine Tob Res. 2010;12(5):489–499. doi:10.1093/ntr/ntq032.
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. 4th ed. Washington, DC: American Psychiatric Association; 2000.
  • World Health Organization. International statistical classification of diseases and related health problems - 10th revision. Geneva Switzerland: World Health Organization; 2010.
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders, DSM-5. 5th ed. Arlington, VA: American Psychiatric Association; 2013.
  • Hooper MW, Zhao W, Byrne MM, Davila E, Caban-Martinez A, Dietz NA, Parker DF, Huang Y, Messiah A, Lee DJ. Menthol cigarette smoking and health, Florida 2007 BRFSS. Am J Health Behav. 2011;31(1):3–14. doi:10.5993/AJHB.35.3.3.
  • Benowitz NL, Dains KM, Dempsey D, Havel C, Wilson M, Jacob P., 3rd. Urine menthol as a biomarker of mentholated cigarette smoking. Cancer Epidemiol Biomarkers Prev. 2010;19:3013–3019. doi:10.1158/1055-9965.EPI-10-0706.
  • Brody AL, Mukhin AG, La Charite J, Ta K, Farahi J, Sugar CA, Mamoun MS, Vellios E, Archie M, Kozman M, Phuong J, Arlorio F, Mandelkern MA. Up-regulation of nicotinic acetylcholine receptors in menthol cigarette smokers. Int J Neuropsychopharmacol. 2013;16:957–966. doi:10.1017/S1461145712001022.
  • Okuyemi KS, Faseru B, Sanderson Cox L, Bronars CA, Ahluwalia JS. Relationship between menthol cigarettes and smoking cessation among African American light smokers. Addiction. 2007;102:1979–1986. doi:10.1111/j.1360-0443.2007.02010.x.
  • Allen B, Jr., Unger JB. Sociocultural correlates of menthol cigarette smoking among adult African Americans in Los Angeles. Nicotine Tob Res. 2007;9:447–451. doi:10.1080/14622200701239647.
  • Collins CC, Moolchan ET. Shorter time to first cigarette of the day in menthol adolescent cigarette smokers. Addict Behav. 2006;31:1460–1464. doi:10.1016/j.addbeh.2005.10.001.
  • DiFranza JR, Savageau JA, Fletcher K, Ockene JK, Rigotti NA, McNeill AD, Coleman M, Wood C. Recollections and repercussions of the first inhaled cigarette. Addict Behav. 2004;29:261–272. doi:10.1016/j.addbeh.2003.08.002.
  • Faseru B, Choi WS, Krebill R, Mayo MS, Nollen NL, Okuyemi KS, Ahluwalia JS, Cox LS. Factors associated with smoking menthol cigarettes among treatment-seeking African American light smokers. Addict Behav. 2011;36:1321–1344. doi:10.1016/j.addbeh.2011.07.015.
  • Li J, Paynter J, Arroll B. A cross-sectional study of menthol cigarette preference by 14- to 15-year-old smokers in New Zealand. Nicotine Tob Res. 2012;14:857–863. doi:10.1093/ntr/ntr299.
  • Marsh L, McGee R, Gray A. A refreshing poison: one-quarter of young New Zealand smokers choose menthol. Aust New Zealand J Public Health. 2012;36:495–496. doi:10.1111/j.1753-6405.2012.00926.x.
  • Muscat JE, Chen G, Knipe A, Stellman SD, Lazarus P, Richie JP Jr. Effects of menthol on tobacco smoke exposure, nicotine dependence, and NNAL glucuronidation. Cancer Epidemiol Biomarkers Prev. 2009;18(1):35–41. doi:10.1158/1055-9965.EPI-08-0744.
  • Okuyemi KS, Ahluwalia JS, Ebersole-Robinson M, Catley D, Mayo MS, Resnicow K. Does menthol attenuate the effect of bupropion among African American smokers? Addiction. 2003;98:1387–1393. doi:10.1046/j.1360-0443.2003.00443.x.
  • Okuyemi KS, Ebersole-Robinson M, Nazir N, Ahluwalia JS. African-American menthol and nonmenthol smokers: differences in smoking and cessation experiences. J Natl Med Assoc. 2004;96:1208–1211.
  • Reitzel LR, Etzel CJ, Cao Y, Okuyemi KS, Ahluwalia JS. Associations of menthol use with motivation and confidence to quit smoking. Am J Health Behav. 2013a;37:629–634. doi:10.5993/AJHB.37.5.6.
  • Reitzel LR, Li Y, Stewart DW, Cao Y, Wetter DW, Waters AJ, Vidrine JI. Race moderates the effect of menthol cigarette use on short-term smoking abstinence. Nicotine Tob Res. 2013b;15:883–889. doi:10.1093/ntr/nts335.
  • Winhusen TM, Adinoff B, Lewis DF, Brigham GS, Gardin JG 2nd, Sonne SC, Theobald J, Ghitza U. A tale of two stimulants: mentholated cigarettes may play a role in cocaine, but not methamphetamine, dependence. Drug Alcohol Depend. 2013;133:845–851. doi:10.1016/j.drugalcdep.2013.09.002.
  • Rojewski AM, Toll BA, O’Malley SS. Menthol cigarette use predicts treatment outcomes of weight-concerned smokers. Nicotine Tob Res. 2014;16:115–119. doi:10.1093/ntr/ntt137.
  • Curtin GM, Sulsky SI, Van Landingham C, Marano KM, Graves MJ, Ogden MW, Swauger JE. Primary measures of dependence among menthol compared to non-menthol cigarette smokers in the United States. Regul Toxicol Pharmacol. 2014;69(3):451–466. doi:10.1016/j.yrtph.2014.05.011.
  • DeVito EE, Valentine GW, Herman AI, Jensen KP, Sofuoglu M. Effect of menthol-preferring status on response to intravenous nicotine. Tob Reg Sci. 2016;2(4):317–328. doi:10.18001/TRS.2.4.4.
  • Fagan P, Pohkrel P, Herzog T, Pagano I, Vallone D, Trinidad DR, Sakuma KL, Sterling K, Fryer CS, Moolchan E. Comparisons of three nicotine dependence scales in a multiethnic sample of young adult menthol and non-menthol smokers. Drug Alcohol Depend. 2015;149:203–211. doi:10.1016/j.drugalcdep.2015.02.005.
  • Hsu PC, Lan RS, Brasky TM, Marian C, Cheema AK, Ressom HW, Loffredo CA, Pickworth WB, Shields PG. Menthol smokers: metabolomic profiling and smoking behavior. Cancer Epidemiol Biomarkers Prev. 2017;26(1):51–60. doi:10.1158/1055-9965.EPI-16-0124.
  • Jao NC, Veluz-Wilkins AK, Smith MJ, Carroll AJ, Blazekovic S, Leone FT, Tyndale RF, Schnoll RA, Hitsman B. Does menthol cigarette use moderate the effect of nicotine metabolism on short-term smoking cessation? Exp Clin Psychopharmacol. 2017;25(3):216–222. doi:10.1037/pha0000124.
  • Kasza KA, Hyland AJ, Bansal-Travers M, Vogl LM, Chen J, Evans SE, Fong GT, Cummings KM, O’Connor RJ. Switching between menthol and nonmenthol cigarettes: findings from the U.S. cohort of the international tobacco control four country survey. Nicotine Tob Res. 2014;16(9):1255–1265. doi:10.1093/ntr/ntu098.
  • Young-Wolff KC, Hickman NJ 3rd, Kim R, Gali K, Prochaska JJ. Correlates and prevalence of menthol cigarette use among adults with serious mental illness. Nicotine Tob Res. 2015;17(3):285–291. doi:10.1093/ntr/ntu141.
  • Watson CV, Richter P, de Castro BR, Sosnoff C, Potts J, Clark P, McCraw J, Yan X, Chambers D, Watson C. Smoking behavior and exposure: results of a menthol cigarette crossover study. Am J Health Behav. 2017;41(3):309–319. doi:10.5993/AJHB.41.3.10.
  • Oncken C, Feinn R, Covault J, Duffy V, Dornelas E, Kranzler HR, Sankey HZ. Genetic vulnerability to menthol cigarette preference in women. Nicotine Tob Res. 2015;17(12):1416–1420. doi:10.1093/ntr/ntv042.
  • Perkins KA, Kunkle N, Karelitz JL. Threshold dose for behavioral discrimination of cigarette nicotine content in menthol vs. non-menthol smokers. Psychopharmacology (Berl). 2017;234(8):1255–1265. doi:10.1007/s00213-017-4563-3.
  • Round EK, Chen P, Taylor AK, Schmidt E. Biomarkers of tobacco exposure decrease after smokers switch to an e-cigarette or nicotine gum. Nicotine Tob Res. 2019;21(9):1239–1247. . doi:10.1093/ntr/nty140.
  • Smith SS, Fiore MC, Baker TB. Smoking cessation in smokers who smoke menthol and nonmenthol cigarettes. Addiction. 2014;109(12):2107–2117. doi:10.1111/add.12661.
  • Zuo Y, Mukhin AG, Garg S, Nazih R, Behm FM, Garg PK, Rose JE. Sex-specific effects of cigarette mentholation on brain nicotine accumulation and smoking behavior. Neuropsychopharmacology. 2015;40(4):884–892. doi:10.1038/npp.2014.263.
  • Veldheer S, Midya V, Lester C, Liao J, Yingst J, Hrabovsky S, Allen SI, Krebs NM, Reinhart L, Evins AE, Horn K, Richie J, Muscat J, Foulds, J. Acceptability of SPECTRUM research cigarettes among participants in trials of reduced nicotine content cigarettes. Tob Reg Sci. 2018;4(1):573–585. doi:10.18001/TRS.4.1.4.
  • Perkins KA, Karelitz JL, Kunkle N. Evaluation of menthol per se on acute perceptions and behavioral choice of cigarettes differing in nicotine content. J Psychopharmacol. 2018;32(3):324–331. doi:10.1177/0269881117742660.
  • Valentine GW, DeVito EE, Jatlow PI, Gueorguieva R, Sofuoglu M. Acute effects of inhaled menthol on the rewarding effects of intravenous nicotine in smokers. J Psychopharmacol. 2018;32(9):986–994. doi:10.1177/0269881118773972.
  • Higgins ST, Bergeria CL, Davis DR, Streck JM, Villanti AC, Hughes JR, Sigmon SC, Tidey JW, Heil SH, Gaalema DE, Stitzer ML, Priest JS, Skelly JM, Reed DD, Bunn JY, Tromblee MA, Arger CA, Miller ME. Response to reduced nicotine content cigarettes among smokers differing in tobacco dependence severity. Prev Med. 2018;117:15–23. doi:10.1016/j.ypmed.2018.04.010.
  • Brunette MF, Ferron JC, Geiger P, Villanti AC. Menthol cigarette use in young adult smokers with severe mental illnesses. Nicotine Tob Res. 2019;21(5):691–694. doi:10.1093/ntr/nty064.
  • Ahijevych K, Szalacha L, Tan A. Effects of menthol flavor cigarettes or total urinary menthol on biomarkers of nicotine and carcinogenic exposure and behavioral measures. Nicotine Tob Res. 2019; 21(9):1189–1197. doi:10.1093/ntr/nty170.
  • Liautaud MM, Leventhal AM, Pang RD. Happiness as a buffer of the association between dependence and acute tobacco abstinence effects in African American smokers. Nic Tobacco Res. 2018;20(10):1215–1222. doi:10.1093/ntr/ntx216.
  • Davis DR, Miller ME, Streck JM, Bergeria CL, Sigmon SC, Tidey JW, Heil SH, Gaalema DE, Villanti AC, Stitzer ML, Priest JS, Bunn JY, Skelly JM, Diaz V, Arger CA, Higgins ST. Response to reduced nicotine content in vulnerable populations: effect of menthol status. Tob Regul Sci.2019;5(2):135–142. doi:10.18001/TRS.5.2.5.
  • Kosiba JD, Hughes MT, LaRowe LR, Zvolensky MJ, Norton PJ, Smits JAJ, Buckner JD, Ditre JW. Menthol cigarette use and pain reporting among African American adults seeking treatment for smoking cessation. Exp Clin Psychopharmacol. 2019;27(3):276–282. doi:10.1037/pha0000254.
  • Gale N, McEwan M, Eldridge AC, Fearon IM, Sherwood N, Bowen E, McDermott S, Holmes E, Hedge A, Hossack S, Wakenshaw L, Glew J, Camacho OM, Errington G, McAughey J,Murphy J, Liu C, Proctor CJ. Changes in Biomarkers of Exposure on Switching From a Conventional Cigarette to Tobacco Heating Products: A Randomized, Controlled Study in Healthy Japanese Subjects. Nicotine Tob Res. 2019;21(9):1220–1227. doi:10.1093/ntr/nty104.
  • Herbeć A, Zatoński M, Zatoński WA, Janik-Koncewicz K, Mons U, Fong GT, Quah ACK, Driezen P, Demjén T, Tountas Y, Trofor AC, Fernández E, McNeill A, Willemsen M, Vardavas CI, Przewoźniak K; EUREST-PLUS consortium. Dependence, plans to quit, quitting self-efficacy and past cessation behaviours among menthol and other flavoured cigarette users in Europe: The EUREST-PLUS ITC Europe Surveys. Tob. Induc. Dis. 2018;16:A19. doi:. doi:10.18332/tid/111356.
  • Stroud LR, Vergara-Lopez C, McCallum M, Gaffey AE, Corey A, Niaura R. High rates of menthol cigarette use among pregnant smokers: Preliminary findings and call for future research. Nicotine Tob Res. 2019 Aug 12. pii: ntz142. doi:10.1093/ntr/ntz142.[Epub ahead of print].
  • Benowitz NL, Herrera B, Jacob P 3rd. Mentholated cigarette smoking inhibits nicotine metabolism. J Pharmacol Exp Ther. 2004;310(3):1208–1215. doi:10.1124/jpet.104.066902.
  • Miller GE, Jarvik ME, Caskey NH, Segerstrom SC, Rosenblatt MR, McCarthy WJ. Cigarette mentholation increases smokers’ exhaled carbon monoxide levels. Exp Clin Psychopharm. 1994;2(2):154–160. doi:10.1037/1064-1297.2.2.154.
  • Jarvik ME, Tashkin DP, Caskey NH, McCarthy WJ, Rosenblatt MR. Mentholated cigarettes decrease puff volume of smoke and increase carbon monoxide absorption. Physiol Behav. 1994;56(3):563–570. doi:10.1016/0031-9384(94)90302-6.
  • Cubbin C, Soobader MJ, LeClere FB. The intersection of gender and race/ethnicity in smoking behaviors among menthol and non-menthol smokers in the United States. Addiction. 2010;105(Suppl 1):32–8. doi:10.1111/j.1360-0443.2010.03191.x.
  • Fagan P, Moolchan ET, Hart A Jr, Rose A, Lawrence D, Shavers VL, Gibson JT. Nicotine dependence and quitting behaviors among menthol and non-menthol smokers with similar consumptive patterns. Addiction. 2010;105(Suppl 1):55–74. doi:10.1111/j.1360-0443.2010.03190.x.
  • Fernander A, Rayens MK, Zhang M, Adkins S. Are age of smoking initiation and purchasing patterns associated with menthol smoking? Addiction. 2010;105(Suppl 1):39–45. doi:10.1111/j.1360-0443.2010.03188.x.
  • Gandhi KK, Foulds J, Steinberg MB, Lu SE, Williams JM. Lower quit rates among African American and Latino menthol cigarette smokers at a tobacco treatment clinic. Int J Clin Pract. 2009;63(3):360–367. doi:10.1111/j.1742-1241.2008.01969.x.
  • Hyland A, Garten S, Giovino GA, Cummings KM. Mentholated cigarettes and smoking cessation: findings from COMMIT. Tob Control. 2002;11:135–139. doi:10.1136/tc.11.2.135.
  • Hymowitz N, Corle D, Royce J, Hartwell T, Corbett K, Orlandi M, Piland N. Smokers’ baseline characteristics in the COMMIT trial. Prev Med. 1995;24(5):503–508. doi:10.1006/pmed.1995.1080.
  • Jones MR, Apelberg BJ, Tellez-Plaza M, Samet JM, Navas-Acien A. Menthol cigarettes, race/ethnicity, and biomarkers of tobacco use in U.S. adults: the 1999-2010 National Health and Nutrition Examination Survey (NHANES). Cancer Epidemiol Biomarkers Prev. 2013a;22:224–232. doi:10.1158/1055-9965.EPI-12-0912.
  • Lawrence D, Rose A, Fagan P, Moolchan ET, Gibson JT, Backinger CL. National patterns and correlates of mentholated cigarette use in the United States. Addiction. 2010;105(Suppl 1):13–31. doi:10.1111/j.1360-0443.2010.03203.x.
  • Pletcher MJ, Hulley BJ, Houston T, Kiefe CI, Benowitz N, Sidney S. Menthol cigarettes, smoking cessation, atherosclerosis, and pulmonary function: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arch Intern Med. 2006;166:1915–1922. doi:10.1001/archinte.166.17.1915.
  • Rosenbloom J, Rees VW, Reid K, Wong J, Kinnunen T. A cross-sectional study on tobacco use and dependence among women: does menthol matter? Tob Induc Dis. 2012;10:19. doi:10.1186/1617-9625-10-19.
  • Stahre M, Okuyemi KS, Joseph AM, Fu SS. Racial/ethnic differences in menthol cigarette smoking, population quit ratios and utilization of evidence-based tobacco cessation treatments. Addiction. 2010;105(Suppl 1):75–83. doi:10.1111/j.1360-0443.2010.03200.x.
  • Curtin GM, Sulsky SI, Van Landingham C, Marano KM, Graves MJ, Ogden MW, Swauger JE. Measures of initiation and progression to increased smoking among current menthol compared to non-menthol cigarette smokers based on data from four U.S. government surveys. Regul Toxicol Pharmacol. 2014;70(2):446–456. doi:10.1016/j.yrtph.2014.08.001.
  • Sulsky SI, Fuller WG, Van Landingham C, Ogden MW, Swauger JE, Curtin GM. Evaluating the association between menthol cigarette use and the likelihood of being a former versus current smoker. Regul Toxicol Pharmacol. 2014;70(1):231-241. Erratum in: Regul Toxicol Pharmacol. 2015 Oct;73(1):114–115. doi:10.1016/j.yrtph.2015.06.012.
  • Cohn AM, Rose SW, D’Silva J, Villanti AC. Menthol smoking patterns and smoking perceptions among youth: findings from the Population Assessment of Tobacco and Health Study. Am J Prev Med. 2019;56(4):e107–e116. doi:10.1016/j.amepre.2018.11.027.
  • Emond JA, Soneji S, Brunette MF, Sargent JD. Flavour capsule cigarette use among US adult cigarette smokers. Tob Control. 2018;27(6):650–655. doi:10.1136/tobaccocontrol-2017-054198.
  • Rath JM, Villanti AC, Williams VF, Richardson A, Pearson JL, Vallone DM. Patterns of longitudinal transitions in menthol use among US young adult smokers. Nicotine Tob Res. 2015;17(7):839–846. doi:10.1093/ntr/ntu247.
  • Park SJ, Foreman MG, Demeo DL, Bhatt SP, Hansel NN, Wise RA, Soler X, Bowler RP. Menthol cigarette smoking in the COPDGene cohort: relationship with COPD, comorbidities and CT metrics. Respirology. 2015;20(1):108–114. doi:10.1111/resp.12421.
  • Fagan P, Pokhrel P, Herzog TA, Pagano IS, Franke AA, Clanton MS, Alexander LA, Trinidad DR, Sakuma KL, Johnson CA, Moolchan ET. Nicotine metabolism in young adult daily menthol and nonmenthol smokers. Nicotine Tob Res. 2016;18(4):437–446. doi:10.1093/ntr/ntv109.
  • Jain RB. Trends in serum cotinine concentrations among daily cigarette smokers: data from NHANES 1999-2010. Sci Total Environ. 2014;472:72–77. doi:10.1016/j.scitotenv.2013.11.002.
  • Alexander LA, Crawford T, Mendiondo MS. Occupational status, work-site cessation programs and policies and menthol smoking on quitting behaviors of US smokers. Addiction. 2010;105(Suppl 1):95–104. doi:10.1111/j.1360-0443.2010.03227.x.
  • Giovino GA, Villanti AC, Mowery PD, Sevilimedu V, Niaura RS, Vallone DM, Abrams DB. Differential trends in cigarette smoking in the USA: Is menthol slowing progress? Tob Control. 2015;24(1):28–37. Epub 2013 Aug 30. doi:10.1136/tobaccocontrol-2013-051159.
  • D’Silva J, Boyle RG, Lien R, Rode P, Okuyemi KS. Cessation outcomes among treatmentseeking menthol and nonmenthol smokers. Am J Prev Med. 2012;43(5 Suppl 3):S242–S248. doi:10.1016/j.amepre.2012.07.033.
  • Hersey JC, Ng SW, Nonnemaker JM, Mowery P, Thomas KY, Vilsaint MC, Allen JA, Haviland ML. Are menthol cigarettes a starter product for youth? Nicotine Tob Res. 2006;8(3):403–413. doi:10.1080/14622200600670389.
  • Kong G, Singh N, Camenga D, Cavallo D, Krishnan-Sarin S. Menthol cigarette and marijuana use among adolescents. Nicotine Tob Res. 2013;15(12):2094–2099. doi:10.1093/ntr/ntt102.
  • Reyes-Guzman CM, Pfeiffer RM, Lubin J, Freedman ND, Cleary SD, Levine PH, Caporaso NE. Determinants of light and intermittent smoking in the United States: results from three pooled national health surveys. Cancer Epidemiol Biomarkers Prev. 2017;26(2):228–239. doi:10.1158/1055-9965.EPI-16-0028.
  • Scheuermann TS, Nollen NL, Cox LS, Reitzel LR, Berg CJ, Guo H, Resnicow K, Ahluwalia JS. Smoking dependence across the levels of cigarette smoking in a multiethnic sample. Addict Behav. 2015;43:1–6. doi:10.1016/j.addbeh.2014.11.017.
  • Gubner NR, Williams DD, Pagano A, Campbell BK, Guydish J. Menthol cigarette smoking among individuals in treatment for substance use disorders. Addict Behav. 2018;80:135–141. doi:10.1016/j.addbeh.2018.01.015.
  • Resnicow K, Zhou Y, Scheuermann TS, Nollen NL, Ahluwalia JS. Unplanned quitting in a triethnic sample of U.S. smokers. Nicotine Tob Res. 2014;16(6):759–765. doi:10.1093/ntr/ntt272.
  • Schauer GL, Peters EN, Rosenberry Z, Kim H. Trends in and characteristics of marijuana and menthol cigarette use among current cigarette smokers, 2005-2014. Nicotine Tob Res. 2018;20(3):362–369.
  • Nguyen MA, Reitzel LR, Kendzor DE, Businelle MS. Perceived cessation treatment effectiveness, medication preferences, and barriers to quitting among light and moderate/heavy homeless smokers. Drug Alcohol Depend. 2015;153:341–345. doi:10.1016/j.drugalcdep.2015.05.039.
  • Cohn AM, Ganz O, Dennhardt AA, Murphy JG, Ehlke S, Cha S, Graham AL. Menthol cigarette smoking is associated with greater subjective reward, satisfaction, and “throat hit”, but not greater behavioral economic demand. Addict Behav. 2020;101:106108. Epub 2019(a) Aug 21. doi:10.1016/j.addbeh.2019.106108.
  • Ahijevych K, Parsley LA. Smoke constituent exposure and stage of change in black and white women cigarette smokers. Addict Behav. 1999; 24:115–20. doi:10.1016/S0306-4603(98)00031-8.
  • Fu SS, Okuyemi KS, Partin MR, et al. Menthol cigarettes and smoking cessation during an aided quit attempt. Nicotine Tob Res 2008;10:457–62. doi:10.1080/14622200801901914.
  • Ahijevych K, Ford J. The relationships between menthol cigarette preference and state tobacco control policies on smoking behaviors of young adult smokers in the 2006-07 Tobacco Use Supplements to the Current Population Surveys (TUS CPS). Addiction. 2010;105(Suppl 1):46–54. doi:10.1111/j.1360-0443.2010.03201.x.
  • Muscat JE, Liu HP, Stellman SD, Richie JP Jr. Menthol smoking in relation to time to first cigarette and cotinine: results from a community-based study. Regul Toxicol Pharmacol 2012; 63:166–170. doi:10.1016/j.yrtph.2012.03.012.
  • Hickman NJ 3rd, Delucchi KL, Prochaska JJ. Menthol use among smokers with psychological distress: findings from the 2008 and 2009 National Survey on Drug Use and Health. Tob Control. 2014;23:7–13. doi:10.1136/tobaccocontrol-2012-050479.
  • Reitzel LR, Nguyen N, Cao Y, Vidrine JI, Daza P, Mullen PD, Velasquez MM, Li Y, Cinciripini PM, Cofta-Woerpel L, Wetter DW. Race/ethnicity moderates the effect of prepartum menthol cigarette use on postpartum smoking abstinence. Nicotine Tob Res. 2011;13(12):1305–1310. doi:10.1093/ntr/ntr095.
  • Soulakova JN, Danczak RR. Impact of menthol smoking on nicotine dependence for diverse racial/ethnic groups of daily smokers. Healthcare (Basel). 2017;5(1). pii: E2. doi:10.3390/healthcare5010002.
  • Cohn AM, Rose SW, D’Silva J, Villanti AC. Menthol smoking patterns and smoking perceptions among youth: findings from the Population Assessment of Tobacco and Health Study. Am J Prev Med. 2019;56(4):e107–e116. doi:10.1016/j.amepre.2018.11.027.
  • Sanders E, Weitkunat R, Dempsey R. Menthol cigarettes, time to first cigarette and smoking cessation. Beitrage zur Tabakforschung International. 2017; 27(5): 1–32. doi:10.1515/cttr-2017-0003.
  • Holmes LM, Lea Watkins S, Lisha NE, Ling PM. Does experienced discrimination explain patterns of menthol use among young adults? Evidence from the 2014 San Francisco Bay Area Young Adult Health Survey. Subst Use Misuse. 2019;54(7):1106–1114. doi:10.1080/10826084.2018.1560468.
  • Bover MT, Foulds J, Steinberg MB, Richardson D, Marcella SW. Waking at night to smoke as a marker for tobacco dependence: patient characteristics and relationship to treatment outcome. Int J Clin Pract. 2008;62:182–190. doi:10.1111/j.1742-1241.2007.01653.x.
  • Sidney S, Tekawa IS, Friedman GD, Sadler MC, Tashkin DP. Mentholated cigarette use and lung cancer. Arch Intern Med. 1995;155:727–732. doi:10.1001/archinte.1995.00430070081010.
  • Brooks DR, Palmer JR, Strom BL, Rosenberg L. Menthol cigarettes and risk of lung cancer. Am J Epidemiol. 2003;158:609–616. doi:10.1093/aje/kwg182.
  • Muscat JE, Richie JP Jr, Stellman SD. Mentholated cigarettes and smoking habits in whites and blacks. Tob Control. 2002;11(4):368–371. doi:10.1136/tc.11.4.368.
  • Mustonen TK, Spencer SM, Hoskinson RA, Sachs DP, Garvey AJ. The influence of gender, race, and menthol content on tobacco exposure measures. Nicotine Tob Res. 2005;7:581–590. doi:10.1080/14622200500185199.
  • Muilenburg JL, Legge JS., Jr African American adolescents and menthol cigarettes: smoking behavior among secondary school students. J Adolesc Health. 2008;43:570–575. doi:10.1016/j.jadohealth.2008.08.017.
  • Murray RP, Connett JE, Skeans MA, Tashkin DP. Menthol cigarettes and health risks in Lung Health Study data. Nicotine Tob Res. 2007;9:101–107. doi:10.1080/14622200601078418.
  • Mendiondo MS, Alexander LA, Crawford T. Health profile differences for menthol and nonmenthol smokers: findings from the National Health Interview Survey. Addiction. 2010;105(Suppl 1):124–140. doi:10.1111/j.1360-0443.2010.03202.x.
  • Blot WJ, Cohen SS, Aldrich M, McLaughlin JK, Hargreaves MK, Signorello LB. Lung cancer risk among smokers of menthol cigarettes. J Natl Cancer Inst. 2011;103:810–816. doi:10.1093/jnci/djr102.
  • Rostron B. Lung cancer mortality risk for U.S. menthol cigarette smokers. Nicotine Tob Res. 2012;14:1140–1144. doi:10.1093/ntr/nts014.
  • Jones MR, Apelberg BJ, Samet JM, Navas-Acien A. Smoking, menthol cigarettes, and peripheral artery disease in U.S. adults. Nicotine Tob Res 2013b;15:1183–1189. doi:10.1093/ntr/nts253.
  • Rostron B. NNAL exposure by race and menthol cigarette use among U.S. smokers. Nicotine Tob Res. 2013;15:950–956. doi:10.1093/ntr/nts223.
  • Ahijevych KL, Wewers ME. Patterns of cigarette consumption and cotinine levels among African American women smokers. Am J Respir Crit Care Med. 1994;150(5 Pt 1):1229–1233. doi:10.1164/ajrccm.150.5.7952545.
  • Giovino GA, Sidney S, Gfroerer JC, O’Malley PM, Allen JA, Richter PA, Cummings KM. Epidemiology of menthol cigarette use. Nicotine Tob Res. 2004;6 Suppl 1:S67–S81. doi:10.1080/14622203710001649696.
  • Wang J, Roethig HJ, Appleton S, Werley M, Muhammad-Kah R, Mendes P. The effect of menthol containing cigarettes on adult smokers’ exposure to nicotine and carbon monoxide. Regul Toxicol Pharmacol. 2010;57(1):24–30. doi:10.1016/j.yrtph.2009.12.003.
  • Benowitz NL, Dains KM, Dempsey D, Wilson M, Jacob P. Racial differences in the relationship between number of cigarettes smoked and nicotine and carcinogen exposure. Nicotine Tob Res. 2011;13(9):772–783. doi:10.1093/ntr/ntr072.
  • O’Connor RJ, Bansal-Travers M, Carter LP, Cummings KM. What would menthol smokers do if menthol in cigarettes were banned? Behavioral intentions and simulated demand. Addiction. 2012;107(7):1330–1338. doi:10.1111/j.1360-0443.2012.03822.x.
  • Sarkar M, Wang J, Liang Q. Metabolism of nicotine and 4-(methylnitrosamino)-l-(3-pyridyl)-lbutanone (NNK) in menthol and non-menthol cigarette smokers. Drug Metab Lett. 2012;6:198–206. doi:10.2174/1872312811206030007.
  • Gan WQ, Estus S, Smith JH. Association between overall and mentholated cigarette smoking with headache in a nationally representative sample. Headache. 2016;56(3):511–518. doi:10.1111/head.12778.
  • Munro HM, Tarone RE, Wang TJ, Blot WJ. Menthol and nonmenthol cigarette smoking: allcause deaths, cardiovascular disease deaths, and other causes of death among Blacks and whites. Circulation. 2016;133(19):1861–1866.
  • Thihalolipavan S, Jung M, Jasek J, Chamany S. Menthol smokers in large-scale nicotine replacement therapy program. Am J Public Health. 2014;104(11):e3–4. doi:10.2105/AJPH.2014.302168.
  • Azagba S, Minaker LM, Sharaf MF, Hammond D, Manske S. Smoking intensity and intent to continue smoking among menthol and non-menthol adolescent smokers in Canada. Cancer Causes Control. 2014;25(9):1093–1099. doi:10.1007/s10552-014-0410-6.
  • Shiffman S, Scholl S. Increases in Cigarette Consumption and Decreases in Smoking Intensity When Nondaily Smokers Are Provided With Free Cigarettes. Nicotine Tob Res. 2018;20(10):1237–1242. doi:10.1093/ntr/ntx221.
  • Fetterman JL, Weisbrod RM, Feng B, Bastin R, Tuttle ST, Holbrook M, Baker G, Robertson RM, Conklin DJ, Bhatnagar A, Hamburg NM. Flavorings in Tobacco Products Induce Endothelial Cell Dysfunction. Arterioscler Thromb Vasc Biol. 2018;38(7):1607–1615.ATVBAHA.118.311156 doi:10.1161/.
  • Zatoński M, Herbeć A, Zatoński W, Przewoźniak K, Janik-Koncewicz K, Mons U, Fong GT, Demjén T, Tountas Y, Trofor AC, Fernández E, McNeil A, Willemsen M, Hummel K, Quah ACK, Kyriakos CN, Vardavas CI; EUREST-PLUS consortium. Characterising smokers of menthol and flavoured cigarettes, their attitudes towards tobacco regulation, and the anticipated impact of the Tobacco Products Directive on their smoking and quitting behaviours: The EUREST-PLUS ITC Europe Surveys. Tob Induc Dis. 2018;16:A4. doi:10.18332/tid/96294.8
  • Kozlovich S, Chen G, Watson CJW, Blot WJ, Lazarus P. Role of l- and d-Menthol in the Glucuronidation and Detoxification of the Major Lung Carcinogen, NNAL.Drug Metab Dispos. 2019;47(12):1388–1396. doi:10.1124/dmd.119.088351.
  • Baker TB, Piper ME, McCarthy DE, Bolt DM, Smith SS, Kim SY, Colby S, Conti D, Giovino GA, Hatsukami D, Hyland A, Krishnan-Sarin S, Niaura R, Perkins KA, Toll BA. Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence. Nicotine Tob Res. 2007;9(Suppl 4):S555–S570.
  • Jones MR, Tellez-Plaza M, Navas-Acien A. Smoking, menthol cigarettes and all-cause, cancer and cardiovascular mortality: evidence from the National Health and Nutrition Examination Survey (NHANES) and a meta-analysis. PLoS One 2013; 8:e77941